University of Iowa Hospitals & Clinics Regulatory Contact 2 is a clinical research site located in Iowa City, Iowa, United States 52242.
Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.
University of Iowa Hospitals & Clinics Regulatory Contact 2 has participated in 3 clinical trials.
Therapeutic areas: PI3K Pathway Activated Tumors, Tumors With CDK4/6 Pathway Activation, Solid Tumor and Hematologic Malignancies.
Sponsors: Novartis Pharmaceuticals, Pfizer.
Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of Iowa Hospitals & Clinics Regulatory Contact 2 has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Iowa Hospitals & Clinics Regulatory Contact 2 has 3 clinical trials on record. Their work covers PI3K Pathway Activated Tumors, Tumors With CDK4/6 Pathway Activation, Solid Tumor and Hematologic Malignancies.
University of Iowa Hospitals & Clinics Regulatory Contact 2 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.